Treatment of pediatric-onset relapsing-remitting multiple sclerosis with high-efficacy therapy reduces the risk for transition across disability states, according to a study published in the May issue of The Lancet Child ...
Apr 15, 2024
0
0
Mutations in the SCN3A gene cause a spectrum of neurological conditions collectively referred to as SCN3A-related neurodevelopmental disorders, which includes different types of epilepsy and brain malformations.
Nov 21, 2023
0
11
The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up.
Jun 21, 2023
0
9
More patients with pediatric-onset multiple sclerosis (POMS) are free of new or newly enlarging (N or NE) T2 hyperintense lesions with dimethyl fumarate (DMF) versus interferon β-1a (IFNβ-1a) treatment, and the annualized ...
Oct 6, 2022
0
45
Patients with pediatric-onset inflammatory bowel disease (IBD) may have an increased risk for developing cancer, particularly gastrointestinal cancers, according to a meta-analysis published online March 1 in JAMA Network ...
Mar 11, 2022
0
4
(HealthDay)—Higher exposure to residential greenspace in childhood is associated with a reduced risk for pediatric-onset inflammatory bowel disease (IBD), according to a study published in the February issue of the American ...
Feb 26, 2021
0
3
(HealthDay)—Pediatric-onset multiple sclerosis (PoMS) is associated with less educational achievement, lower earnings, and greater use of disability benefits throughout the working-age life span, according to a study published ...
Feb 24, 2021
0
4
The first study to examine both chest X-ray and CT imaging findings in teenagers with electronic (e-)cigarette or vaping product use-associated lung injury (EVALI) was published today in the journal Radiology.
Mar 3, 2020
0
2
Age of onset for disease is an important factor affecting clinical outcomes across the life span in patients receiving disease-modifying therapy (DMT) for multiple sclerosis (MS), according to a study published online Feb. ...
Mar 2, 2020
0
1
(HealthDay)—Timing of treatment start is an important predictor of disability accumulation in patients with pediatric-onset multiple sclerosis (MS), according to a study published online Jan. 17 in Multiple Sclerosis and ...
Jan 31, 2020
0
11
